LongeVC | Latest News & Updates - Jan 14, 2025 Release
LongeVC's comparative indices for 2023 show slight improvements in net turnover, equity capital, fixed assets, balance, tangible assets, and liquidity...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
LongeVC
🌎 longevc.comLongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.
LongeVC - Latest News and Updates
- LongeVC's comparative indices for 2023 show slight improvements in net turnover, equity capital, fixed assets, balance, tangible assets, and liquidity.
- Garri Zmudze of LongeVC participated in an investors panel at ARDD2024 discussing the development of the longevity biotechnology industry.
- Artem Trotsyuk, operating partner at LongeVC, noted a trend of larger companies acquiring smaller biotechs to access new medicines and technologies.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.